PART I All references in this report to "Coya," the "Company," "we," "us," or "our" mean Coya Therapeutics, Inc. unless stated otherwise or the context otherwise indicates. Overview We are a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). Tregs are a subpopulation of T-lymphocytes consisting of CD4+CD25high hFOXP3+ cells that suppress inflammatory responses. Tregs were first discovered in 1995 by Dr. Shim...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-16 | 2025-12-31 | 0001193125-26-107281 | EDGAR | 96K words |
| 2025-03-18 | 2024-12-31 | 0000950170-25-040782 | EDGAR | — |
| 2024-03-19 | 2023-12-31 | 0000950170-24-033161 | EDGAR | — |
| 2023-03-29 | 2022-12-31 | 0000950170-23-010599 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001193125-25-276058 | EDGAR | 22K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-106934 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0000950170-25-069824 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0000950170-24-121837 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0000950170-24-095075 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-057056 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0000950170-23-060718 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0000950170-23-039354 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0000950170-23-020076 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-02 | 0001193125-26-139094 | EDGAR | 4K words |
| 2026-03-16 | 0001193125-26-107276 | EDGAR | — |
| 2026-01-30 | 0001193125-26-030531 | EDGAR | — |
| 2026-01-20 | 0001193125-26-016017 | EDGAR | — |
| 2026-01-08 | 0001193125-26-007042 | EDGAR | — |
| 2025-12-17 | 0001193125-25-321737 | EDGAR | — |
| 2025-11-12 | 0001193125-25-276022 | EDGAR | — |
| 2025-10-27 | 0001193125-25-250709 | EDGAR | — |
| 2025-09-02 | 0001193125-25-193450 | EDGAR | — |
| 2025-08-12 | 0000950170-25-106932 | EDGAR | — |
75 total filings indexed. 52 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001835022 |
| Ticker | COYA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.coyatherapeutics.com |
| Listed | 2022-12-29 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report